Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 28.35%96.14K | 569.08%89.83K | 393.27%288.97K | 172.41%119.63K | 10,259.85%81.01K | 110,060.29%74.91K | -2.85%13.43K | 808.69%58.58K | 43.91K | 782 |
| Selling and administrative expenses | 33.32%86.97K | 669.47%82.3K | 299.40%228.79K | 189.92%125.6K | 38,287.32%27.26K | 95,832.35%65.23K | -22.60%10.7K | 788.51%57.28K | --43.32K | --71 |
| -General and administrative expense | 33.32%86.97K | 669.47%82.3K | 299.40%228.79K | 189.92%125.6K | 38,287.32%27.26K | 95,832.35%65.23K | -22.60%10.7K | 788.51%57.28K | --43.32K | --71 |
| Other operating expenses | -5.20%9.17K | 175.75%7.53K | 4,526.29%60.19K | -1,112.88%-5.98K | 7,461.04%53.76K | --9.68K | --2.73K | --1.3K | --590 | --711 |
| Operating profit | -28.35%-96.14K | -569.08%-89.83K | -393.27%-288.97K | -172.41%-119.63K | -10,259.85%-81.01K | -110,060.29%-74.91K | 2.85%-13.43K | -808.69%-58.58K | -43.91K | -782 |
| Net non-operating interest income (expenses) | -1.4K | 0 | ||||||||
| Non-operating interest expense | --1.4K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Other net income (expenses) | ||||||||||
| Income before tax | -30.21%-97.54K | -569.08%-89.83K | -393.27%-288.97K | -172.41%-119.63K | -10,259.85%-81.01K | -110,060.29%-74.91K | 2.85%-13.43K | -808.69%-58.58K | -43.91K | -782 |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -30.21%-97.54K | -569.08%-89.83K | -393.27%-288.97K | -172.41%-119.63K | -10,259.85%-81.01K | -110,060.29%-74.91K | 2.85%-13.43K | -808.69%-58.58K | -43.91K | -782 |
| Net income continuous operations | -30.21%-97.54K | -569.08%-89.83K | -393.27%-288.97K | -172.41%-119.63K | -10,259.85%-81.01K | -110,060.29%-74.91K | 2.85%-13.43K | -808.69%-58.58K | ---43.91K | ---782 |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -30.21%-97.54K | -569.08%-89.83K | -393.27%-288.97K | -172.41%-119.63K | -10,259.85%-81.01K | -110,060.29%-74.91K | 2.85%-13.43K | -808.69%-58.58K | -43.91K | -782 |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -30.21%-97.54K | -569.08%-89.83K | -393.27%-288.97K | -172.41%-119.63K | -10,259.85%-81.01K | -110,060.29%-74.91K | 2.85%-13.43K | -808.69%-58.58K | -43.91K | -782 |
| Diluted earnings per share | 0 | -544.12%-0.004 | -416.41%-0.014 | -195.28%-0.006 | -11,011.11%-0.004 | -115,433.33%-0.0035 | 2.82%-0.0006 | -809.73%-0.0027 | -0.002 | -0 |
| Basic earnings per share | 0 | -544.12%-0.004 | -416.41%-0.014 | -195.28%-0.006 | -11,011.11%-0.004 | -115,433.33%-0.0035 | 2.82%-0.0006 | -809.73%-0.0027 | -0.002 | -0 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.